APP and Alzheimer disease: Furthermore, when AD transgenic mice (APP23) are crossed with an obese mouse model (ob/ob) the resulting offspring (APP+-ob/ob) show worse cognitive deficits and vascular inflammation that appear before significant Aβ deposition (Takeda et al., 2010).